In the administration of a lymphatic planar drug in which an anticancer drug is administered in a lymph node, a preferable pharmaceutical composition is provided. A metabolic antagonist, and a plant alkaloid-type anticancer agent as an active ingredient, wherein the pharmaceutical composition is administered in a lymph node.
展开▼